Institutional Ownership
Jyong Biotech Ltd
CUSIP G83116106SHSMENSQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
17
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 258.8K | $556.3K |
| 2 | Geode Capital Management, LLC | 64.2K | $138.1K |
| 3 | Ubs Group AG | 37.4K | $80.3K |
| 4 | Millennium Management LLC | 14.6K | $31.4K |
| 5 | Vanguard Personalized Indexing Management, LLC | 13.9K | $29.9K |
| 6 | China Universal Asset Management Co., Ltd. | 13.2K | $28.3K |
| 7 | Tower Research Capital LLC (Trc) | 11.7K | $25.2K |
| 8 | Morgan Stanley | 6.3K | $13.5K |
| 9 | Barclays PLC | 5.2K | $11.2K |
| 10 | Jpmorgan Chase & Co | 5.7K | $10.8K |